Written and maintained by CASRAI Editorial Board
Published
On this page
Form FDA 3514 is the CDRH Premarket Review Submission Cover Sheet, a fill-in-the-blank form from FDA’s Center for Devices and Radiological Health that collects the administrative facts about a device submission: who is applying, what the device is, how it is classified, which earlier submissions relate to it and which standards and guidance were used. FDA’s 510(k) content page says the cover sheet should be used for all 510(k) submissions, and the form’s own Section A lists many other pathways it can introduce.
This page walks through the 8/23 revision of the form, section by section, as described on the official FDA form on 2026-11-18. It describes the form and how it fits into a submission; it is not regulatory advice, and FDA’s own pages remain the authority for what a given submission must contain.
What Form FDA 3514 is and who runs it
The form is titled “CDRH Premarket Review Submission Cover Sheet” and is published by FDA. It carries OMB control number 0910-0120, which is the federal paperwork-clearance number for the collection, and states a burden estimate of about half an hour per response. The header asks for the date of submission, a User Fee Payment ID number and, if known, an FDA submission document number.
The form’s printed Paperwork Reduction Act statement says that an agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number. It also tells filers not to send the completed form to the PRA staff address printed on it. The form goes in the submission, not to that address.
FDA publishes it as a fillable PDF. FDA’s 510(k) forms page notes that, depending on the browser, you may need to download the form to enable the fillable fields. Because the file is an Adobe form, a browser’s built-in viewer may show only a waiting placeholder; downloading it and opening it in Adobe Acrobat or Reader is the practical route.
The 510(k) is not itself a form. FDA’s content page says so directly, and describes the 510(k) as an organized, tabulated document in which 21 CFR 807 Subpart E sets out the required information. Form 3514 is a convenient front-end to that document, not a replacement for it.
Which submissions use the cover sheet
Section A, Type of Submission, is where the filer says what kind of submission the cover sheet introduces. The 8/23 form lists these choices:
- PMA and PDP
- 510(k), with Traditional, Special and Abbreviated options and third-party variants
- CLIA, including the CLIA Categorization Record and CLIA Waiver by Application, plus a Dual Track option for a 510(k) combined with a CLIA waiver
- Q-Submission, with Pre-Submission, Informational Meeting, Submission Issue Meeting, Day 100 Meeting, Agreement Meeting, Determination Meeting and Study Risk Determination options
- IDE and HDE
- De Novo, either Direct or Post-NSE
- 513(g)
- Appeal
- Emergency Use Authorization and Pre-EUA
- Expanded Access to Devices
- Class II Exemption Petition
- Other
For 510(k)s, FDA’s content page is explicit: “Use the CDRH Premarket Review Submission Cover Sheet and the Screening Checklist for all Premarket Notification 510(k) Submissions.” It describes the cover sheet as a “fill-in-the-blank” format that satisfies many of the 510(k) requirements, and says that using it may help expedite processing. The same page allows a cover letter to carry the information instead: if you choose not to use the cover sheet, the cover letter should include all the elements the cover sheet contains.
FDA’s page says the sheet should be used and then describes the cover-letter alternative, and this page reports only that wording. For a 513(g) request, see the separate guide to the FDA 513(g) request for information, which is one of the types Section A names.
What the form collects, Sections A to K
The data table below maps every section of the 8/23 revision to what it asks for. A few sections deserve more detail than a table cell allows.
Applicant, correspondent and device (Sections B to E)
Section B identifies the applicant or sponsor: company, address, contact and the FEI or establishment registration number. Section C identifies the Official Correspondent, for example a consultant or a 510(k) third party, and can be repeated for more than one. Section D records the intended-use population in age bands: adults only (over 21), adults and pediatrics, neonate (birth to 28 days), infant (29 days to 2 years), child (2 to 12 years), adolescent (12 to 18 years), and two transitional adolescent options covering ages 18 to 21. Section E records the trade name and the common or generic name, with room for up to 12 trade names.
These fields line up with items that 21 CFR 807.87 requires in every premarket notification. The regulation asks for the device name, covering both the trade or proprietary name and the common, usual or classification name (807.87(a)), and for the establishment registration number of the owner or operator, if applicable (807.87(b)). The editorial point is simple: a completed Sections B and E means those regulatory items are stated in one place, which is why FDA describes the sheet as satisfying many requirements.
Prior submissions and classification (Sections F and G)
Section F asks for the FDA document numbers of all prior related submissions, regardless of outcome, or a statement that there is no prior submission. Section G asks for the classification panel, the device class (I, II, III or unclassified), the product code or codes and the C.F.R. section. Under 807.87(c) the notification must state the class under section 513 of the Act and, if known, the panel, or a statement and basis if the owner or operator determines the device has not been classified.
Reason for application (Section H)
Section H is the only part of the form that changes by pathway. H1 covers PMA, PDP and HDE; H2 covers IDE; H3 covers Q-Submission and asks which kind of feedback is wanted (a face-to-face meeting, a teleconference, an email response) or whether meeting minutes are being submitted; H4 covers 510(k) and asks for predicate information; H5 covers De Novo; H6 covers CLIA. In H4 the predicate is entered with its 510(k) number, submitter and product code, and each device is marked as the Primary Predicate (A) or as a Predicate or Reference Device (B).
Sites, standards and guidance (Sections I to K)
Section I lists manufacturing, packaging and sterilization sites by FEI number, including contract manufacturers, contract sterilizers and repackagers or relabelers. The form adds that submitting this information does not affect Registration and Listing. Section J records the voluntary consensus standards used: the FDA recognition number (or NR if the standard is not recognized), whether a Declaration of Conformity or General Use applies, the standards development organization, the designation number including year, the title, the location in the submission and whether there were deviations. The form points to FDA’s guidance on the appropriate use of voluntary consensus standards in premarket submissions for medical devices. For background on recognition, see the explainer on FDA-recognized consensus standards. Section K asks for the titles of the CDRH guidance documents used.
How to complete the form, step by step
- Download the current form from FDA and open it in Adobe Acrobat or Reader so the fields work.
- In the header, enter the date of submission and the User Fee Payment ID number; add the FDA submission document number if you already have one.
- Choose the submission type in Section A, including the sub-option that matches your pathway (for a 510(k), Traditional, Special or Abbreviated).
- Complete the applicant (B) and, if a consultant or third party is handling correspondence, the Official Correspondent (C).
- Choose the intended-use population (D) and enter the trade and common names (E).
- List every prior related submission by FDA document number, or state that there is none (F).
- Enter the classification panel, class, product code and C.F.R. section (G).
- Complete only the Section H block for your pathway, such as H4 with the predicate details for a 510(k).
- List the manufacturing, packaging and sterilization sites by FEI number (I), then the standards (J) and the CDRH guidance documents (K) you actually used.
FDA’s content page lists information to have in hand before you begin: the device’s classification, the predicate device or devices, final draft labeling, specifications including engineering drawings and photos, performance data such as bench, animal or clinical testing where applicable, sterilization information where applicable, and any guidance documents specific to the device type. Most of that feeds straight into Sections E to K.
Where the cover sheet sits in a 510(k)
FDA’s content page gives the order of the opening pages. The first page of a 510(k) should be a printed copy of the Medical Device User Fee Cover Sheet, Form FDA 3601. A cover letter, the CDRH Premarket Review Submission Cover Sheet, or both should follow it. The rest of the submission carries the content items FDA lists. FDA also says you are not required to organize the 510(k) into its labeled sections and may modify them to suit the device.
As a sequence of phases, with no calendar dates attached: gather the classification, predicate, labeling, specification and test information; draft the substantive content; complete the cover sheet from that material so the names, class, product code, predicate and standards agree with the body; place the user fee sheet first and the cover sheet or cover letter after it; then assemble the remaining items. For how the electronic submission format changes assembly, see the guide to the eSTAR template for 510(k) and De Novo submissions. User fees themselves are covered in the MDUFA guide.
Common mistakes the form itself warns against
These come from the form’s own instructions and from FDA’s content page, not from outside commentary.
- Treating the cover sheet as the submission. FDA states that the 510(k) is not a form; the sheet introduces a document that still has to contain the required information.
- Leaving Section F blank. The form asks for all prior related submissions, regardless of outcome, or a statement that there is no prior submission. A blank field answers neither.
- Entering a recognition number for an unrecognized standard. Section J says to write NR when the standard is not recognized.
- Dropping the year from a standard’s designation. The form asks for the designation number including year, as well as the title and the developing organization.
- Assuming Section I updates your FDA registration. The form says submitting site information does not affect Registration and Listing.
- Skipping a second correspondent. Section C can be repeated, so a consultant and a third party can both be listed.
- Mailing the completed form to the PRA staff address. The form says not to.
- Completing every Section H block. H1 to H6 are pathway-specific; fill in the one that matches Section A.
Related forms and documents
The table below places the cover sheet beside the other opening documents FDA’s 510(k) content page names. Form FDA 356h is a different FDA form; see the Form FDA 356h term so the two are not confused.
| Document | What FDA’s content page says | Position |
|---|---|---|
| Medical Device User Fee Cover Sheet (Form FDA 3601) | Printed copy is the first page of a 510(k); instructions are available online | First page |
| Cover letter | May carry the information the cover sheet covers; must include all the sheet’s elements if the sheet is not used | After the user fee sheet |
| CDRH Premarket Review Submission Cover Sheet (Form FDA 3514) | Should be used for all 510(k) submissions; fill-in-the-blank; satisfies many requirements; may expedite processing | After the user fee sheet, alone or with a cover letter |
| Screening or acceptance checklist | Used with the cover sheet to prepare the submission; assures required elements are provided | Listed as recommended content |
| Statement of Indications for Use | A separate content item in the list of 510(k) contents | Content item |
| 510(k) Summary or Statement | A separate content item in the list of 510(k) contents | Content item |
Sources
- FDA: Form FDA 3514, CDRH Premarket Review Submission Cover Sheet (8/23), checked 2026-11-18
- FDA: Content of a 510(k), checked 2026-11-18
- FDA: 510(k) Forms, checked 2026-11-18
- Legal Information Institute (Cornell): 21 CFR 807.87, Information required in a premarket notification submission, checked 2026-11-18
Data: Form FDA 3514 (8/23) sections and what each collects
Compiled from the text of Form FDA 3514 (CDRH Premarket Review Submission Cover Sheet, 8/23 revision) as published by FDA and read on 2026-11-18. Each row is one lettered section or Section H pathway block with a summary of the fields the form asks for.
Coverage: United States.
| Section | Heading on the form | What the form collects |
|---|---|---|
| A | Type of Submission | Submission type and sub-option: PMA/PDP, 510(k) (Traditional, Special, Abbreviated, third-party), CLIA, Q-Submission meeting types, IDE, HDE, De Novo, 513(g), Appeal, EUA, Pre-EUA, Expanded Access, Dual Track, Class II Exemption Petition, Other |
| B | Applicant/Sponsor | Company, address, contact and FEI or establishment registration number |
| C | Official Correspondent | Correspondent such as a consultant or 510(k) third party; repeatable |
| D | Intended Use Population | Age band: adults only (over 21), adults and pediatrics, neonate, infant, child, adolescent, transitional adolescent options |
| E | Product Information | Trade name and common or generic name; up to 12 trade names |
| F | Prior Related Submissions | FDA document numbers of all prior related submissions regardless of outcome, or a statement that there is none |
| G | Product Classification | Classification panel, device class (I, II, III, unclassified), product code(s), C.F.R. section |
| H1 | Reason for Application: PMA/PDP/HDE | Pathway-specific block for PMA, PDP and HDE |
| H2 | Reason for Application: IDE | Pathway-specific block for IDE |
| H3 | Reason for Application: Q-Submission | Requested feedback: face-to-face meeting, teleconference or email response, or submission of meeting minutes |
| H4 | Reason for Application: 510(k) | Predicate: 510(k) number, submitter, product code; marked Primary Predicate (A) or Predicate or Reference Device (B) |
| H5 | Reason for Application: De Novo | Pathway-specific block for De Novo |
| H6 | Reason for Application: CLIA | Pathway-specific block for CLIA |
| I | Manufacturing/Packaging/Sterilization Sites | Sites by FEI number: contract manufacturer, contract sterilizer, repackager or relabeler; does not affect Registration and Listing |
| J | Utilization of Standards | Recognition number (NR if not recognized), Declaration of Conformity or General Use, standards body, designation with year, title, location in submission, deviation yes or no |
| K | Utilization of CDRH Guidance Documents | Titles of the CDRH guidance documents used |
Sources
- FDA: Form FDA 3514, CDRH Premarket Review Submission Cover Sheet (8/23) (accessed 2026-11-18)
Compiled by CASRAI from the sources above. Free to reuse under CC BY 4.0 with attribution.







